Form 4 · Statement of Changes in Beneficial Ownership · Filed 2026-02-13
Schmid Timothy Files Johnson & Johnson (JNJ) Form 4 - February 13, 2026
Schmid Timothy traded 54.5K JNJ shares worth $8.8M in this Form 4 filing, reported to the SEC on 2026-02-13.
- Insider
- Schmid Timothy
- Issuer
- Johnson & Johnson JNJ · NYSE
- Filed
- Period
- 2026-02-13
- Accession
- 0000200406-26-000036
- Source
- Official filing on sec.gov ↗
Transactions (12)
| Insider | Date | Type | Shares | Price | Value | Own |
|---|---|---|---|---|---|---|
| Schmid Timothy | 2026-02-18 | Sell | 9.0K | $244.53 | $2.2M | Direct |
| Schmid Timothy | 2026-02-18 | Buy | 9.0K | $129.51 | $1.2M | Direct |
| Schmid Timothy | 2026-02-18 | Buy | 13.6K | $115.67 | $1.6M | Direct |
| Schmid Timothy | 2026-02-18 | Sell | 13.6K | $244.20 | $3.3M | Direct |
| Schmid Timothy | 2026-02-15 | Buy | 1.0K | $0.00 | $0.00 | Direct |
| Schmid Timothy | 2026-02-15 | Buy | 1.0K | $0.00 | $0.00 | Direct |
| Schmid Timothy | 2026-02-15 | Sell | 15 | $243.45 | $3.7K | Direct |
| Schmid Timothy | 2026-02-15 | Sell | 448 | $243.45 | $109.1K | Direct |
| Schmid Timothy | 2026-02-13 | Buy | 499 | $0.00 | $0.00 | Direct |
| Schmid Timothy | 2026-02-13 | Sell | 1.8K | $244.55 | $444.1K | Direct |
| Schmid Timothy | 2026-02-13 | Buy | 4.4K | $0.00 | $0.00 | Direct |
| Schmid Timothy | 2026-02-13 | Sell | 8 | $244.55 | $2.0K | Direct |
| Net change | +4.6K | −$3.3M | ||||
About Johnson & Johnson
Johnson & Johnson is a multinational corporation engaged in the research, development, production, and sale of a broad range of healthcare products. Primarily known for its pharmaceuticals, medical devices, and consumer health products, Johnson & Johnson has a significant presence in the global healthcare industry. It develops medications for a variety of fields such as immunology, oncology, neurology, infectious diseases, and vaccines. The company also produces a wide array of medical devices for surgery, orthopedics, and cardiovascular health. In addition to pharmaceuticals, Johnson & Johnson is renowned for its consumer health products, including baby care, skin and hair care, wound care, and over-the-counter pharmaceuticals, with well-recognized brands like Band-Aid, Tylenol, and Neutrogena. Operating globally, the corporation's extensive portfolio and commitment to healthcare innovation make it a pivotal player in the industry, ensuring it remains influential in addressing worldwide health challenges and advancing medical technology.
Track JNJ insider activity
Get alerted when Johnson & Johnson executives buy or sell their shares.